Parthenolide has limited effects on nuclear factor-κβ increases and worsens survival in lipopolysaccharide-challenged C57BL/6J mice

Cytokine

Volumn 33, Issue 6, 2006, Pages 299-308

  Li, Xuemei ^a   Cui, Xizhong ^a   Li, Yan ^a   Fitz, Yvonne ^a   Hsu, Lewis ^b   Eichacker, Peter Q ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Anti inflammatory agent; Lipopolysaccharide; Signaling molecules; Treatment

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MIGRATION INHIBITION FACTOR; PARTHENOLIDE; PLACEBO; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG INHIBITION; HAZARD ASSESSMENT; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SURVIVAL RATE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CYTOKINES; DISEASE MODELS, ANIMAL; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; NF-KAPPA B; SESQUITERPENES; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; SURVIVAL RATE;

ANIMALIA;

EID: 33744533883     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2006.03.002     Document Type: Article

References (36)

1. Natanson C., Hoffman W.D., Suffredini A.F., Eichacker P.Q., and Danner R.L. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 120 (1994) 771-783
2. Yang R.B., Mark M.R., Gray A., Huang A., Xie M.H., Zhang M., et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395 (1998) 284-288
3. Kirschning C.J., Wesche H., Merrill Ayres T., and Rothe M. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 188 (1998) 2091-2097
4. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162 (1999) 3749-3752
5. Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14 (1996) 649-683
6. Blackwell T.S., Yull F.E., Chen C.L., Venkatakrishnan A., Blackwell T.R., Hicks D.J., et al. Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. Am J Respir Crit Care Med 162 (2000) 1095-1101
7. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (1999) 6853-6866
8. Bohrer H., Qiu F., Zimmermann T., Zhang Y., Jllmer T., Mannel D., et al. Role of NFkappaB in the mortality of sepsis. J Clin Invest 100 (1997) 972-985
9. Christman J.W., Lancaster L.H., and Blackwell T.S. Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med 24 (1998) 1131-1138
10. Bork P.M., Schmitz M.L., Kuhnt M., Escher C., and Heinrich M. Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-kappaB. FEBS Lett 402 (1997) 85-90
11. Kwok B.H., Koh B., Ndubuisi M.I., Elofsson M., and Crews C.M. The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. Chem Biol 8 (2001) 759-766
12. Lyss G., Knorre A., Schmidt T.J., Pahl H.L., and Merfort I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J Biol Chem 273 (1998) 33508-33516
13. Garcia-Pineres A.J., Lindenmeyer M.T., and Merfort I. Role of cysteine residues of p65/NF-kappaB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential. Life Sci 75 (2004) 841-856
14. Hehner S.P., Hofmann T.G., Droge W., and Schmitz M.L. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. J Immunol 163 (1999) 5617-5623
15. Mazor R.L., Menendez I.Y., Ryan M.A., Fiedler M.A., and Wong H.R. Sesquiterpene lactones are potent inhibitors of interleukin 8 gene expression in cultured human respiratory epithelium. Cytokine 12 (2000) 239-245
16. Hehner S.P., Heinrich M., Bork P.M., Vogt M., Ratter F., Lehmann V., et al. Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta. J Biol Chem 273 (1998) 1288-1297
17. Uchi H., Arrighi J.F., Aubry J.P., Furue M., and Hauser C. The sesquiterpene lactone parthenolide inhibits LPS- but not TNF-alpha-induced maturation of human monocyte-derived dendritic cells by inhibition of the p38 mitogen-activated protein kinase pathway. J Allergy Clin Immunol 110 (2002) 269-276
18. Sheehan M., Wong H.R., Hake P.W., Malhotra V., O'Connor M., and Zingarelli B. Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents. Mol Pharmacol 61 (2002) 953-963
19. Sheehan M., Wong H.R., Hake P.W., and Zingarelli B. Protective effects of isohelenin, an inhibitor of nuclear factor kappaB, in endotoxic shock in rats. J Endotoxin Res 8 (2002) 99-107
20. Sheehan M., Wong H.R., Hake P.W., and Zingarelli B. Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis. Crit Care Med 31 (2003) 2263-2270
21. Liu S.F., Ye X., and Malik A.B. In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol 159 (1997) 3976-3983
22. Sorokina E.M., Merlo Jr. J.J., and Tsygankov A.Y. Molecular mechanisms of the effect of herpesvirus saimiri protein StpC on the signaling pathway leading to NF-kappaB activation. J Biol Chem 279 (2004) 13469-13477
23. Fiebich B.L., Lieb K., Engels S., and Heinrich M. Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells. J Neuroimmunol 132 (2002) 18-24
24. Yip K.H., Zheng M.H., Feng H.T., Steer J.H., Joyce D.A., and Xu J. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity. J Bone Miner Res 19 (2004) 1905-1916
25. Wong H.R., and Menendez I.Y. Sesquiterpene lactones inhibit inducible nitric oxide synthase gene expression in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 262 (1999) 375-380
26. Hwang D., Fischer N.H., Jang B.C., Tak H., Kim J.K., and Lee W. Inhibition of the expression of inducible cyclooxygenase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases. Biochem Biophys Res Commun 226 (1996) 810-818
27. Smolinski A.T., and Pestka J.J. Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb(1) (ginseng) and parthenolide (feverfew). Food Chem Toxicol 41 (2003) 1381-1390
28. Arnalich F., Garcia-Palomero E., Lopez J., Jimenez M., Madero R., Renart J., et al. Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun 68 (2000) 1942-1945
29. Meduri G.U., Headley S., Kohler G., Stentz F., Tolley E., Umberger R., et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107 (1995) 1062-1073
30. Roggero E., Perez A., Tamae-Kakazu M., Piazzon I., Nepomnaschy I., Wietzerbin J., et al. Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities. Clin Exp Immunol 128 (2002) 421-428
31. Mizuhara H., Kuno M., Seki N., Yu W.G., Yamaoka M., Yamashita M., et al. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice. Hepatology 27 (1998) 513-519
32. Ichinose T., Takano H., Sadakane K., Yanagisawa R., Yoshikawa T., Sagai M., et al. Mouse strain differences in eosinophilic airway inflammation caused by intratracheal instillation of mite allergen and diesel exhaust particles. J Appl Toxicol 24 (2004) 69-76
33. Tabibiazar R., Wagner R.A., Spin J.M., Ashley E.A., Narasimhan B., Rubin E.M., et al. Mouse strain-specific differences in vascular wall gene expression and their relationship to vascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 302-308
34. Cobb J.P., Natanson C., Hoffman W.D., Lodato R.F., Banks S., Koev C.A., et al. N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 176 (1992) 1175-1182
35. Lopez A., Lorente J.A., Steingrub J., Bakker J., McLuckie A., Willatts S., et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32 (2004) 21-30
36. Zhang S., Ong C.N., and Shen H.M. Critical roles of intracellular thiols and calcium in parthenolide-induced apoptosis in human colorectal cancer cells. Cancer Lett 208 (2004) 143-153